111 related articles for article (PubMed ID: 25875971)
21. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
Bartella L; Thakur SB; Morris EA; Dershaw DD; Huang W; Chough E; Cruz MC; Liberman L
Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182
[TBL] [Abstract][Full Text] [Related]
22. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
[TBL] [Abstract][Full Text] [Related]
23. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
[TBL] [Abstract][Full Text] [Related]
24. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
25. Extramammary Findings on Breast MR Examinations: Frequency, Clinical Relevance, and Patient Outcomes.
Niell BL; Bennett D; Sharma A; Gazelle GS
Radiology; 2015 Jul; 276(1):56-64. PubMed ID: 25584711
[TBL] [Abstract][Full Text] [Related]
26. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
Kinkel K; Helbich TH; Esserman LJ; Barclay J; Schwerin EH; Sickles EA; Hylton NM
AJR Am J Roentgenol; 2000 Jul; 175(1):35-43. PubMed ID: 10882243
[TBL] [Abstract][Full Text] [Related]
27. Undiagnosed breast cancer at MR imaging: analysis of causes.
Pages EB; Millet I; Hoa D; Doyon FC; Taourel P
Radiology; 2012 Jul; 264(1):40-50. PubMed ID: 22523324
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution.
Bae SJ; Cha YJ; Eun NL; Ji JH; Kim D; Lee J; Ahn SG; Son EJ; Jeong J
Radiology; 2021 Oct; 301(1):47-56. PubMed ID: 34254854
[TBL] [Abstract][Full Text] [Related]
29. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
Orel SG; Rosen M; Mies C; Schnall MD
Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
[TBL] [Abstract][Full Text] [Related]
30. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
31. Rectal cancer: comparison of accuracy of local-regional staging with two- and three-dimensional preoperative 3-T MR imaging.
Kim H; Lim JS; Choi JY; Park J; Chung YE; Kim MJ; Choi E; Kim NK; Kim KW
Radiology; 2010 Feb; 254(2):485-92. PubMed ID: 20093520
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and outcome of enhancing foci followed on breast MRI with management implications.
Ha R; Sung J; Lee C; Comstock C; Wynn R; Morris E
Clin Radiol; 2014 Jul; 69(7):715-20. PubMed ID: 24680120
[TBL] [Abstract][Full Text] [Related]
33. PPV(3) of suspicious breast MRI findings.
Smith H; Chetlen AL; Schetter S; Mack J; Watts M; Zhu JJ
Acad Radiol; 2014 Dec; 21(12):1553-62. PubMed ID: 25262952
[TBL] [Abstract][Full Text] [Related]
34. Changes in recall type and patient treatment following implementation of screening digital breast tomosynthesis.
Lourenco AP; Barry-Brooks M; Baird GL; Tuttle A; Mainiero MB
Radiology; 2015 Feb; 274(2):337-42. PubMed ID: 25247407
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients.
Wang LJ; Wu P; Li XX; Luo R; Wang DB; Guan WB
World J Surg Oncol; 2018 Dec; 16(1):234. PubMed ID: 30558621
[TBL] [Abstract][Full Text] [Related]
36. Descriptors of Malignant Non-mass Enhancement of Breast MRI: Their Correlation to the Presence of Invasion.
Machida Y; Shimauchi A; Tozaki M; Kuroki Y; Yoshida T; Fukuma E
Acad Radiol; 2016 Jun; 23(6):687-95. PubMed ID: 26976623
[TBL] [Abstract][Full Text] [Related]
37. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
[TBL] [Abstract][Full Text] [Related]
38. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
[TBL] [Abstract][Full Text] [Related]
39. Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement.
Carbonaro LA; Verardi N; Di Leo G; Sardanelli F
Invest Radiol; 2010 Mar; 45(3):114-20. PubMed ID: 20065856
[TBL] [Abstract][Full Text] [Related]
40. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
